p53 is associated with cellular microtubules and is transported to the nucleus by dynein

Nature Cell Biology

Volumn 2, Issue 10, 2000, Pages 709-717

  Giannakakou, Paraskevi ^a   Sackett, Dan L ^b   Ward, Yvona ^a   Webster, Kevin R ^c   Blagosklonny, Mikhail V ^a   Fojo, Tito ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYNEIN ADENOSINE TRIPHOSPHATASE; LEPTOMYCIN B; PROTEIN MDM2; PROTEIN P21; PROTEIN P53; TAXOL; TUBULIN; VINCRISTINE;

ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; CYTOSKELETON; DNA DAMAGE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MICROTUBULE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT;

ACTIVE TRANSPORT, CELL NUCLEUS; DYNEIN ATPASE; FATTY ACIDS, UNSATURATED; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; MICROTUBULE-ASSOCIATED PROTEINS; MICROTUBULES; MOLECULAR MOTORS; PACLITAXEL; PRECIPITIN TESTS; PROTEIN BINDING; PROTEIN P53; TUBULIN; TUMOR CELLS, CULTURED; VINCRISTINE;

EID: 0034306461     PISSN: 14657392     EISSN: None     Source Type: Journal    
DOI: 10.1038/35036335     Document Type: Article

References (46)

1. Ko, L. J. & Prives, C. p53: puzzle and paradigm. Genes Dev. 10, 1054-1072 (1996).
2. Levine, A. J. p53, the cellular gatekeeper for growth and division. Cell 88, 323-331 (1997).
3. Vogelstein, B. & Kinzler, K. W. p53 function and dysfunction. Cell 70, 523-536 (1992).
4. Cross, S. M. et al. A p53-dependent mouse spindle checkpoint. Science 267, 1353-1356 (1995).
5. Fukasawa, K., Choi, T., Kuriyama, R., Rulong, S. & Vande, W. G. Abnormal centrosome amplification in the absence of p53. Science 271, 1744-1747 (1996).
6. Kastan, M. B., Onyekwere, O., Sidransky, D., Vogelstein, B. & Craig, R. W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51, 6304-6311 (1991).
7. Lane, D. P. Cancer. p53, guardian of the genome. Nature 358, 15-16 (1992).
8. Prives, C. Signaling to p53: breaking the MDM2-p53 circuit. Cell 95, 5-8 (1998).
9. el-Deiry, W. S. et al. WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825 (1993).
10. Miyashita, T. & Reed, J. C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80, 293-299 (1995).
11. Polyak, K., Xia, Y., Zweier, J. L., Kinzler, K. W. & Vogelstein, B. A model for p53-induced apoptosis. Nature 389, 300-305 (1997).
12. Hollstein, M., Sidransky, D., Vogelstein, B. & Harris, C. C. p53 mutations in human cancers. Science 253, 49-53 (1991).
13. Levine, A. J., Momand, J. & Finlay, C. A. The p53 tumour suppressor gene. Nature 351, 453-456 (1991).
14. Momand, J., Zambetti, G. P., Olson, D. C., George, D. & Levine, A. J. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69, 1237-1245 (1992).
15. Oliner, J. D. et al. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature 362, 857-860 (1993).
16. Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J. & Howley, P. M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63, 1129-1136 (1990).
17. Moll, U. M. et al. Cytoplasmic sequestration of wild-type p53 protein impairs the G1 checkpoint after DNA damage. Mol. Cell. Biol. 16, 1126-1137 (1996).
18. Moll, U. M., Riou, G. & Levine, A. J. Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion. Proc. Natl Acad. Sci. USA 89, 7262-7266 (1992).
19. Schlamp, C. L., Poulsen, G. L., Nork, T. M. & Nickells, R. W. Nuclear exclusion of wild-type p53 in immortalized human retinoblastoma cells. J. Natl Cancer Inst. 89, 1530-1536 (1997).
20. Bosari, S. et al. Cytoplasmic accumulation of p53 protein: an independent prognostic indicator in colorectal adenocarcinomas. J. Natl Cancer Inst. 86, 681-687 (1994).
21. Sun, X. F. et al. Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma. Lancet 340, 1369-1373 (1992).
22. Freedman, D. A. & Levine, A. J. Nuclear export is required for degradation of endogenous p53 by MDM2 and human papillomavirus E6. Mol. Cell Biol. 18, 7288-7293 (1998).
23. Giannakakou, P. et al. Paclitaxel-resistant human ovarian cancer cells have mutant beta-tubulins that exhibit impaired paclitaxel-driven polymerization. J. Biol. Chem. 272, 17118-17125 (1997).
24. Giannakakou, P. et al. Paclitaxel selects for mutant or pseudo-null p53 in drug resistance associated with tubulin mutations in human cancer. Oncogene 19, 3078-3085 (2000).
25. Hyman, A. A. & Karsenti, E. Morphogenetic properties of microtubules and mitotic spindle assembly. Cell 84, 401-410 (1996).
26. Jordan, M. A. & Wilson, L. Microtubules and actin filaments: dynamic targets for cancer chemotherapy. Curr. Opin. Cell Biol. 10, 123-130 (1998).
27. Gundersen, G. G. & Cook, T. A. Microtubules and signal transduction. Curr. Opin. Cell Biol. 11, 81-94 (1999).
28. Stommel, J. M. et al. A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking. EMBO J. 18, 1660-1672 (1999).
29. Goodson, H. V., Valetti, C. & Kreis, T. E. Motors and membrane traffic. Curr. Opin. Cell Biol. 9, 18-28 (1997).
30. Okada, Y. & Hirokawa, N. A processive single-headed motor: kinesin superfamily protein KIF1A. Science 283, 1152-1157 (1999).
31. Hirokawa, N. Kinesin and dynein superfamily proteins and the mechanism of organelle transport. Science 279, 519-526 (1998).
32. Burkhardt, J. K., Echeverri, C. J., Nilsson, T. Vallee, R. B. Overexpression of the dynamitin (p50) subunit of the dynactin complex disrupts dynein-dependent maintenance of membrane organelle distribution. J. Cell Biol. 139, 469-484 (1997).
33. Klotzke, O., Etzrodt, D., Hohenberg, H., Bohn, W. & Deppert, W. Cytoplasmic retention of mutant tsp53 is dependent on an intermediate filament protein (vimentin) scaffold. Oncogene 16, 3423-3434 (1998).
34. Jimenez, G. S., Khan, S. H., Stommel, J. M. & Wahl, G. M. p53 regulation by post-translational modification and nuclear retention in response to diverse stresses. Oncogene 18, 7656-7665 (1999).
35. Maxwell, S. A. et al. Simian virus 40 large T antigen and p53 are microtubule-associated proteins in transformed cells. Cell Growth Differ. 2, 115-127 (1991).
36. Blagosklonny, M. V. et al. Taxol induction of p21WAF1 and p53 requires c-raf-1. Cancer Res. 55, 4623-4626 (1995).
37. Kapeller, R., Toker, A., Cantley, L. C. & Carpenter, C. L. Phosphoinositide 3-kinase binds constitutively to alpha/beta-tubulin and binds to gamma-tubulin in response to insulin. J. biol. Chem. 270, 25985-25991 (1995).
38. Magnelli, L. The old and the new in p53 functional regulation. Biochem. Mol. Med. 62, 3-10 (1997).
39. Chai, Y. L. et al. The second BRCT domain of BRCA1 proteins interacts with p53 and stimulates transcription from the p21WAF1/CIP1 promoter. Oncogene 18, 263-268 (1999).
40. Ouchi, T., Monteiro, A. N., August, A., Aaronson, S. A. & Hanafusa, H. BRCA1 regulates p53-dependent gene expression. Proc. Natl Acad. Sci. USA 95, 2302-2306 (1998).
41. Hsu, L. C. & White, R. L. BRCA1 is associated with the centrosome during mitosis. Proc. Natl Acad. Sci. USA 95, 12983-12988 (1998).
42. Sackett, D. L., Knipling, L. & Wolff, J. Isolation of microtubule protein from mammalian brain frozen for extended periods of time. Protein Expr. Purif. 2, 390-393 (1991).
43. Takenaka, I., Morin, F., Seizinger, B. R. & Kley, N. Regulation of the sequence-specific DNA binding function of p53 by protein kinase C and protein phosphatases J. Biol. Chem. 270, 5405-5411 (1995).
44. Wolff, J, Sackett, D. L. & Knipling, L. Cation selective promotion of tubulin polymerization by alkali metal chlorides. Protein Sci. 5, 2020-2028 (1996).
45. Balczon, R., Varden, C. E. & Schroer, T. A. Role for microtubules in centrosome doubling in Chinese hamster ovary cells. Cell Motil. Cytoskeleton 42, 60-72 (1999).
46. Horton, R. M., Cai, Z. L., Ho, S. N. & Pease, L. R. Gene splicing by overlap extension: tailor-made genes using the polymerase chain reaction. Biotechniques 8, 528-531 (1990).